Daewoong Hosts Nabota Summit in Bali

Daewoong Pharmaceutical gathered 35 key opinion leaders from 11 countries for a three-day medical summit in Bali, Indonesia.

Updated on Nov. 3, 2026 in Beauty

Gouache-painted editorial illustration of a clear glass vial on a stone ledge with a tropical sea and palms behind it, evoking an international Bali medical summit.
Daewoong Pharmaceutical hosted 35 key opinion leaders from 11 countries at a three-day Nabota medical summit in Bali, Indonesia, from October 29 to 31. AI Illustration. Upload story photo >

Daewoong Pharmaceutical held the NMC EXCLUSIVE Global KOL Summit Bali 2026 in Bali, Indonesia, from October 29 to 31, 2026. The event followed Nabota cumulative global sales surpassing KRW 1 trillion in June 2026.

Why it matters

The summit was planned to solidify Nabota's academic standing in line with its sales growth since receiving FDA approval in 2019. It gave physicians from multiple countries a structured setting to compare clinical cases and approaches.

Nabota cumulative global sales exceeded KRW 1 trillion ($714.29 million) in June 2026, with an average annual growth rate of 57% since its 2019 FDA approval. The company-reported figures are not independently verified in the available extraction.

The players

Daewoong Pharmaceutical

A South Korean pharmaceutical company that markets Nabota and runs educational programs for medical professionals.

Yoon Joon-soo

The leader of Daewoong Pharmaceutical's Nabota Business Division, overseeing the product's commercial and educational efforts.

The details

Medical professionals from South Korea, Indonesia, Saudi Arabia, and Brazil presented Nabota treatment experiences on the first day. Participants visited BWork Uluwatu and the NULOOK Clinic, and training on the second day continued through case-based R.E.A.L. Guidelines.

Timeline

  1. June 2026: Nabota cumulative sales surpassed KRW 1 trillion.

  2. October 29-31, 2026: The NMC Global KOL Summit was held in Bali.

Market Trajectory

The summit follows Nabota's sales growth since its 2019 FDA approval, with the company reporting an average annual growth rate of 57% over that period. The event is framed as a way to build academic credibility alongside that commercial expansion.

For people considering aesthetic treatments, the summit reflects a growing emphasis on physician training and shared clinical approaches. Readers evaluating such procedures can ask providers about their training and experience with the specific product.

The takeaway

Medical education programs like this one aim to standardize how aesthetic treatments are administered across countries. Patients benefit from choosing providers who can explain their training and treatment protocols clearly.

Further reading

Explore more on Beauty trends and treatments shaping the industry.

Source note: This article includes information reported by Business Korea.